Lilly Novo Nordisk Battle Intensifies as Obesity Drugs Surge
Eli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
Using Index Level To Set Risk Tolerance helps you align your portfolio with your comfort and goals. Grasp practical steps to calibrate risk in real markets.
27,657 articlesEli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
A widow spent $1.1 million on cruise-ship art in the years after her husband’s death, shining a light on grief-driven...
A routine check request at a local credit union led to an account freeze and a wider fraud investigation. This articl...
The Federal Reserve held rates steady this week, but uncertainty remains. Three principal concerns are rattling inves...
A new Milken-Harris poll shows 80% of Americans want government-backed AI workforce programs now, with 68% feeling th...
Micron Technology jumped on a bold target upgrade, lifting questions about sustainability as the AI memory cycle fuel...
Take-Two CEO Strauss Zelnick is directing a record-setting $1.5 billion launch budget for GTA VI, a move investors wi...
A landmark housing bill becomes law without Trump’s signature, signaling a setback for GOP messaging ahead of midterm...
Fed’s Bowman signals a hawkish tilt, saying she’s penciled in three rate cuts by year-end 2026 to bolster the labor m...
Windfalls from settlements and inheritances are surging in 2026, but experts warn these gains often fade within a few...
RH is poised to release Q1 results after the bell, with investors watching for margins, international exposure, and t...
Bed Bath & Beyond reveals a three-pilot strategy to build a housing platform after purchasing Fathom Holdings. The pl...